BIOCON

Biocon is a leading Indian biopharmaceutical company focused on: Biosimilars (its main growth driver) Generic formulations Research services via Syngene International It operates globally, especially in the US, Europe, and emerging markets. 📉 Price Trend & Technical View (General) Over the past few years, the stock has been range-bound to mildly bearish It has struggled to sustain rallies due to: Margin pressure High debt after acquisition of Viatris biosimilars business Key zones (approximate): Support: ₹240–260 Resistance: ₹320–350 A breakout above resistance with volume is needed for a strong uptrend.